Industry Developments
United States
BMI View: If successfully developed and marketed, Bristol-Myer Squibb (BMS)'s investigational combination immuno-oncology therapy will potentially be a leader in the market for skin...
2013-05-20Ecuador
BMI View: The steadily growing Ecuadorian pharmaceutical market will provide revenue-earning opportunities for Takeda. However, the limited market size and low per capita spending on...
2013-03-22BMI View: Despite the undoubted clinical and commercial success of traditional chemotherapy, demand for new targeted cancer therapies is likely to remain high. This will provide continued...
2013-03-22United States
BMI View: The outcome of the recent compulsory licence application to manufacture a generic version of Bristol-Myers Squibb (BMS)'s Sprycel (dasatinib) will likely favour the Indian...
2013-03-19BMI View: Bayer's strong presence in Latin America has helped the company deliver above expectation sales in 2012. However, the company did not outperform the general market in the...
2013-03-19Brazil
BMI View: The Brazilian government is determined to foster the country's capacity to develop and produce innovative products and services, as globalisation has sharpened Brazil's need...
2013-03-18Venezuela
BMI View: In the aftermath of Hugo Chávez's death, increasing concerns among domestic and foreign businesses have arisen. These are directed towards the rising political...
2013-03-15BMI View: As global macroeconomic headwinds continue to restrict medicine sales in developed markets (primarily Europe, but also the US, and to a lesser extent Japan, Australia and...
2013-03-13
